Merck

A predictive ligand-based Bayesian model for human drug-induced liver injury.

Drug metabolism and disposition: the biological fate of chemicals (2010-09-17)
Sean Ekins, Antony J Williams, Jinghai J Xu
RESUMEN

Drug-induced liver injury (DILI) is one of the most important reasons for drug development failure at both preapproval and postapproval stages. There has been increased interest in developing predictive in vivo, in vitro, and in silico models to identify compounds that cause idiosyncratic hepatotoxicity. In the current study, we applied machine learning, a Bayesian modeling method with extended connectivity fingerprints and other interpretable descriptors. The model that was developed and internally validated (using a training set of 295 compounds) was then applied to a large test set relative to the training set (237 compounds) for external validation. The resulting concordance of 60%, sensitivity of 56%, and specificity of 67% were comparable to results for internal validation. The Bayesian model with extended connectivity functional class fingerprints of maximum diameter 6 (ECFC_6) and interpretable descriptors suggested several substructures that are chemically reactive and may also be important for DILI-causing compounds, e.g., ketones, diols, and α-methyl styrene type structures. Using Smiles Arbitrary Target Specification (SMARTS) filters published by several pharmaceutical companies, we evaluated whether such reactive substructures could be readily detected by any of the published filters. It was apparent that the most stringent filters used in this study, such as the Abbott alerts, which captures thiol traps and other compounds, may be of use in identifying DILI-causing compounds (sensitivity 67%). A significant outcome of the present study is that we provide predictions for many compounds that cause DILI by using the knowledge we have available from previous studies. These computational models may represent cost-effective selection criteria before in vitro or in vivo experimental studies.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
2-Bromophenol, 98%
Sigma-Aldrich
Rifampicin, suitable for plant cell culture, BioReagent, ≥97% (HPLC), crystalline
Sigma-Aldrich
Rifampicin, ≥97% (HPLC), powder
Sigma-Aldrich
Biotin, meets USP testing specifications
Sigma-Aldrich
Phentolamine methanesulfonate salt, ≥98% (TLC), powder
Supelco
Isoniazid, analytical standard, ≥99% (TLC)
Sigma-Aldrich
Biotin, powder, BioReagent, suitable for cell culture, suitable for insect cell culture, suitable for plant cell culture, ≥99%
Sigma-Aldrich
(±)-Chlorpheniramine maleate salt, ≥99% (perchloric acid titration)
Sigma-Aldrich
Allyl alcohol, ≥98.5%
Sigma-Aldrich
Caffeine, anhydrous, 99%, FCC, FG
Sigma-Aldrich
Hydrazine solution, 35 wt. % in H2O
Sigma-Aldrich
Phenothiazine, ≥98%
Sigma-Aldrich
Valeric acid, ≥99%
Sigma-Aldrich
3-Acetamidophenol, 97%
Sigma-Aldrich
4-Bromophenol, 99%
Sigma-Aldrich
Biotin, ≥99% (HPLC), lyophilized powder
Sigma-Aldrich
Naproxen, meets USP testing specifications
Sigma-Aldrich
Praziquantel, anthelminic, neurogenic
Sigma-Aldrich
Furazolidone
Sigma-Aldrich
Allyl alcohol, ≥99%
Sigma-Aldrich
5,5-Diphenylhydantoin, ≥98%
Sigma-Aldrich
Ketoprofen, meets USP testing specifications
Sigma-Aldrich
Hydrochlorothiazide, crystalline
Sigma-Aldrich
Betaine hydrochloride, ≥99%
Sigma-Aldrich
5-Azacytidine, ≥98% (HPLC)
Sigma-Aldrich
5-Azacytidine, Hybri-Max, γ-irradiated, lyophilized powder, BioXtra, suitable for hybridoma
Supelco
Mettler-Toledo Calibration substance ME 18872, Caffeine, analytical standard, for the calibration of the thermosystem 900, traceable to primary standards (LGC)
Supelco
4-Aminophenol, PESTANAL®, analytical standard
Sigma-Aldrich
Ergocalciferol, ≥98.0% (sum of enantiomers, HPLC)
Supelco
Hexachlorophene, PESTANAL®, analytical standard